Top 5 News Stories 9/1 – 9/7

1) How A $440,000 Drug Is Turning Alexion Into Biotech’s New Innovation Powerhouse Forbes 09/05/2012

Just days after announcing that its COO will step down and be replaced by former principal and manager of Georgia Institute of Technology’s Advanced Technology Development Center, Galectin Therapeutics says it’s moving its headquarters from Newton to Atlanta, but will maintain a lab in the Boston area. Link

2) Ocular Therapeutix enrolls patients in Phase 3 trial Mass High Tech – 09/04/2012

Ocular Therapeutix Inc. of Bedford has completed enrollment of a Phase 3 clinical trial of its ReSure Sealant, a polyethylene glycol (PEG)-based hydrogel intended for use during cataract surgery, according to a statement from the company. Link

3) FDA panel backs Novartis cystic fibrosis drug Reuters – 09/05/2012

Drug advisers on Wednesday backed a new form of Novartis AG’s inhaled antibiotic that treats a lung infection linked to cystic fibrosis. A panel of outside advisers to the Food and Drug Administration voted 13 to 1 that Novartis had demonstrated that its tobramycin inhalation powder, or TIP, was safe and effective. Link

4) GnuBIO moves into new, larger space in Kendall Mass High Tech – 09/05/2012

GnuBIO Inc. is moving into a new Kendall Square lab and office space that’s more than double the size of its current space in anticipation of the pending product launch its desktop gene sequencing system. Link

5) Ex-Obama Advisers Push First-Ever Budget For $2.8 Trillion Health Care System Huffington Post– 09/02/2012

Some of President Barack Obama’s former advisers are proposing major changes aimed at controlling health care costs as political uncertainty hovers over his health law. Call it Health Care Overhaul, Version 2.0. Their biggest idea is a first-ever budget for the nation’s $2.8-trillion health care system, through negotiated limits on public and private spending in each state. Link